Benzothiazoles having histamine H3 receptor activity

Details for Australian Patent Application No. 2007229492 (hide)

Owner High Point Pharmaceuticals, LLC

Inventors Hohlweg, Rolf; Lundbeck, Jane Marie; Andersen, Knud Erik; Dorwald, Florencio Zaragoza; Christensen, Inge Thoger

Agent Shelston IP

Pub. Number AU-B-2007229492

PCT Pub. Number WO2007/110364

Priority 06111820.4 28.03.06 EP; 60/787,478 30.03.06 US; 06112425.1 10.04.06 EP; 60/903,503 26.02.07 US; 60/794,288 21.04.06 US; 06026875.2 24.12.06 EP

Filing date 22 March 2007

Wipo publication date 4 October 2007

Acceptance publication date 3 November 2011

International Classifications

C07D 277/82 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 263/58 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

4 September 2008 PCT application entered the National Phase

  PCT publication WO2007/110364 Priority application(s): WO2007/110364

13 November 2008 Alteration of Name

  The name of the applicant has been altered to High Point Pharmaceuticals, LLC Amendments

3 November 2011 Application Accepted

  Published as AU-B-2007229492

1 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007229502-Benzimidazole derivatives and their use for modulating the GABAA receptor complex

2007229491-Methods for treating cognitive and other disorders